The groundbreaking therapy of tirzepatide peptide represents a significant development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide033942.link4blogs.com/62927542/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment